BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30597308)

  • 1. Comprehensive circular RNA profiling of proliferative vitreoretinopathy and its clinical significance.
    Yao J; Hu LL; Li XM; Shan K; Zhou RM; Ge HM; Yao MD; Jiang Q; Zhao C; Yan B
    Biomed Pharmacother; 2019 Mar; 111():548-554. PubMed ID: 30597308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes.
    Telander DG; Yu AK; Forward KI; Morales SA; Morse LS; Park SS; Gordon LK
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3112-7. PubMed ID: 27294805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of gene expression profile of epiretinal membranes obtained from eyes with proliferative vitreoretinopathy to that of secondary epiretinal membranes.
    Asato R; Yoshida S; Ogura A; Nakama T; Ishikawa K; Nakao S; Sassa Y; Enaida H; Oshima Y; Ikeo K; Gojobori T; Kono T; Ishibashi T
    PLoS One; 2013; 8(1):e54191. PubMed ID: 23372684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P38 inhibition reverses TGFβ1 and TNFα-induced contraction in a model of proliferative vitreoretinopathy.
    Schiff L; Boles NC; Fernandes M; Nachmani B; Gentile R; Blenkinsop TA
    Commun Biol; 2019; 2():162. PubMed ID: 31069271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration.
    Oberstein SY; Byun J; Herrera D; Chapin EA; Fisher SK; Lewis GP
    Mol Vis; 2011; 17():1794-805. PubMed ID: 21750605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Cell Protein and Transcriptional Characterization of Epiretinal Membranes From Patients With Proliferative Vitreoretinopathy.
    Laich Y; Wolf J; Hajdu RI; Schlecht A; Bucher F; Pauleikhoff L; Busch M; Martin G; Faatz H; Killmer S; Bengsch B; Stahl A; Lommatzsch A; Schlunck G; Agostini H; Boneva S; Lange C
    Invest Ophthalmol Vis Sci; 2022 May; 63(5):17. PubMed ID: 35579905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic evidence that ABCA4 is vital for traumatic proliferative vitreoretinopathy formation and development.
    Wang M; Li Q; Dong H
    Exp Eye Res; 2019 Apr; 181():232-239. PubMed ID: 30738069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy.
    Amarnani D; Machuca-Parra AI; Wong LL; Marko CK; Stefater JA; Stryjewski TP; Eliott D; Arboleda-Velasquez JF; Kim LA
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):3940-3949. PubMed ID: 28777835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Periostin in the Pathogenesis of Proliferative Vitreoretinopathy].
    Ishikawa K
    Nippon Ganka Gakkai Zasshi; 2015 Nov; 119(11):772-80. PubMed ID: 26685481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting matrix stiffness-induced activation of retinal pigment epithelial cells through the RhoA/YAP pathway ameliorates proliferative vitreoretinopathy.
    Zhang W; Han H
    Exp Eye Res; 2021 Aug; 209():108677. PubMed ID: 34147507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aquaporin-1 expression in proliferative vitreoretinopathy and in epiretinal membranes.
    Motulsky E; Salik D; Janssens X; Pion B; Dufrane R; Chaput F; Bolaky N; Gregoire F; Caspers L; Perret J; Willermain F; Delporte C
    ScientificWorldJournal; 2014; 2014():876208. PubMed ID: 24688444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
    Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
    Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreous M2 Macrophage-Derived Microparticles Promote RPE Cell Proliferation and Migration in Traumatic Proliferative Vitreoretinopathy.
    Song Y; Liao M; Zhao X; Han H; Dong X; Wang X; Du M; Yan H
    Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):26. PubMed ID: 34554178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of proliferative retinopathy-related long noncoding RNAs.
    Zhou RM; Wang XQ; Yao J; Shen Y; Chen SN; Yang H; Jiang Q; Yan B
    Biochem Biophys Res Commun; 2015 Sep; 465(3):324-30. PubMed ID: 26241674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch signaling modulates proliferative vitreoretinopathy via regulating retinal pigment epithelial-to-mesenchymal transition.
    Zhang J; Yuan G; Dong M; Zhang T; Hua G; Zhou Q; Shi W
    Histochem Cell Biol; 2017 Mar; 147(3):367-375. PubMed ID: 27600720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro.
    Yao H; Ge T; Zhang Y; Li M; Yang S; Li H; Wang F
    FASEB J; 2019 Mar; 33(3):3212-3224. PubMed ID: 30383450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Caveolin-1 for Blocking the Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy.
    Nagasaka Y; Kaneko H; Ye F; Kachi S; Asami T; Kato S; Takayama K; Hwang SJ; Kataoka K; Shimizu H; Iwase T; Funahashi Y; Higuchi A; Senga T; Terasaki H
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):221-229. PubMed ID: 28114583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
    Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
    Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells.
    Wong CA; Potter MJ; Cui JZ; Chang TS; Ma P; Maberley AL; Ross WH; White VA; Samad A; Jia W; Hornan D; Matsubara JA
    Can J Ophthalmol; 2002 Jun; 37(4):211-20. PubMed ID: 12095094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.